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OBJECTIVE: To find an effective, sensitive, specific and noninvasive diagnostic method for cancer.
METHODS: 109 masses from 102 patients with breast lesions smaller than 2 cm in diameter were
divided into three groups to undergo 99mtechnetium-methoxyisobutylisonitrile (99mTc-MIBI) imaging. The
results were compared with their pathology. Twenty cases without breast lesions were selected as a
control group. Abnormal density of 99mTc-MIBI in the breast and a threshold level 10% higher than that
in the counterpart of the healthy breast was regarded as positive.
RESULTS: Of 32 breast cancers, positive imaging appeared in 25. Negative imaging was found in 31
of 38 benign breast lesions. Of 39 nonpalpable breast lesions, five cases were breast cancers and 34
cases benign. Positive MIBI imaging appeared in all of the breast cancers, while in the benign lesions,
four were positive and 30 negative. No positive imaging was found in the control group. The diagnostic
accuracy, sensitivity, specificity, positive predictive value and negative predictive value of 99mTc-MIBI
were 88.4%, 89.2%, 88.0%, 75.0% and 95.3%, respectively.
CONCLUSIONS: 99mTc-MIBI imaging had high sensitivity and accuracy in the diagnosis of breast
cancer, as well as in the differentiation between benign and malignant breast lesions. It could provide
reliable information in confirming the diagnosis in patients with clinically suspected breast cancer.
(Asian J Surg 2002;25(2):126–9)
The incidence of breast cancer is increasing in China
and it will be the most common malignant tumour in
women in the early years of the 21st century.1
99mtechnetium-methoxyisobutylisonitrile (99mTc-MIBI)
breast imaging, an effective, sensitive, specific and
noninvasive diagnostic method for breast cancer detection,
has been attracting the attention of physicians. From
March,1994 to September, 1999, 109 breast masses
smaller than 2 cm in diameter (clinically so-called “early
breast cancer”) in 102 patients in Huashan Hospital were
divided into three groups to undergo 99mTc-MIBI breast
imaging and the results were compared with their
pathology. Twenty cases without breast lesions were
selected as a control group. The results showed that
99mTc-MIBI breast imaging could provide reliable
information for the diagnosis of early breast cancer.
MATERIALS AND METHODS
Patient selection and grouping
Breast cancer
32 women with 32 lesions were included in this group.
All were married women with an average age of 51.2
years (range, 31 to 81 years). Of 32 lesions, 15 were
smaller than 1 cm in diameter and 17 ranged from 1 cm
to 2 cm in diameter. Breast cancer was confirmed by
histopathology.
Benign lesions
38 lesions in 35 women were included in this group.
Among them, 29 were married. The mean age was 40.8




©Excerpta Medica Asia Ltd
Asian Journal of Surgery 127
99mTC-MIBI IMAGING IN BREAST CANCER
than 1 cm in diameter and 22 ranged from 1 cm to 2 cm
in diameter. Postoperative pathology showed that 35
were benign breast lesions and three were chronic mas-
titis or abscesses.
Nonpalpable lesions
35 female patients with 39 lesions were included in
this group. 33 patients were married. Their ages ranged
from 20 to 46 years, with a mean of 40.1 years. 39 lesions
were preoperatively confirmed by ultrasonography. 29
lesions were smaller than 1 cm and 10 were from 1 cm to
2 cm in diameter. 34 benign breast lesions and five breast
cancers were confirmed by pathology after surgery.
Controls
20 married women without breast lesions were in-
cluded in this group. Their mean age was 45.3 years
(range, 24 to 72 years).
Instruments and methods
The ELSCINT APEX 409AG SPECT (ELSCINT, Tel Aviv,
Israel) device was used to perform 99mTc-MIBI breast
imaging. 99mTc-MIBI with a marking rate greater than
95% was supplied by Xinke Co., Shanghai, China.
In order to highlight the lesions, the patient was placed
in a supine position with both arms held up to keep a
wider distance between the breasts and the heart during
the examination. The probe faced the breast directly and
a pro-oblique or lateral image was taken, if necessary.
99mTc-MIBI 925WBq was administered intravenously,
and early and delayed static images were taken after 5
minutes and 60 minutes, respectively.
Image processing
Static images of the lesions were observed. A region of
interest (ROI) was taken in the lesion and in the counter-
part of the contralateral breast. The radiological ratio
between the tumour and the normal tissue (T/N) was
calculated and then compared with that of the contralat-
eral breast. A positive result was considered if the T/N
ratio of the lesion was 10% higher than that of contralat-
eral breast; slightly increased 99mTc-MIBI was considered
if the threshold of 99mTc-MIBI uptake was increased by
less than 10% but was higher than that of the contralateral
breast—this was also considered positive imaging. Nega-
tive imaging was considered when the T/N ratio of the
lesion was equal to that of the contralateral breast.
In calculations, the highest ratio of T/N was regarded as
the diagnostic value whenever early or delayed imaging
was taken and regardless of what position the patient
took.
RESULTS
The sensitivity, specificity, accuracy, positive and
negative predictive value of 99mTc-MIBI breast imaging
was 89.2%, 88.0%, 88.4%, 75.0% and 95.3%, respec-
tively (Table).
In the breast cancer group, positive imaging appeared
in 28 cases (including three cases with slightly increased
99mTc-MIBI breast imaging), and false negative results
appeared in four. The diagnostic accuracy was 87.5%.
In the benign group, false positives appeared in seven
cases (of them, two had slight increases). The diagnostic
accuracy of 99mTc-MIBI breast imaging in this group
was 81.6%. Chronic mastitis was confirmed pathologi-
cally in five patients with false positive 99mTc-MIBI breast
imaging.
In the group of nonpalpable breast lesions, breast
cancer was confirmed in five out of nine cases
with positive 99mTc-MIBI breast imaging (slightly increased
imaging appeared in two). The diagnostic accuracy was
90.0%. Chronic mastitis was confirmed in three
patients who were misdiagnosed. In this group, five
lesions were nonpalpable but 99mTc-MIBI breast imaging
showed an abnormal accumulation of isotope in the
breast. Ultrasound-guided biopsy was performed and the
diagnosis of breast cancer was confirmed pathologically.
In the control group, all 20 patients had normal
99mTc-MIBI breast imaging, although abnormal density of
99mTc-MIBI in right axillary lymph nodes was found in one
patient, in which malignant lymphoma was subsequently
confirmed by lymph node biopsy.
Table. Comparison between results of 99mTc-MIBI
breast imaging and pathology
Group Positive Negative Total
Malignant 28 4 32
Benign 7 31 38
Nonpalpable lesion 5 30 39
Control 0 20 20
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DISCUSSION
99mTc-MIBI has an affinity for malignant tumour tissue
and, thus, the rate of uptake of 99mTc-MIBI is higher in
breast cancer lesions. When the T/N ratio of 99mTc-MIBI
in the breast was higher than or equal to 10%, this
abnormal density could be seen with the naked eye
(Figure 1). It was helpful in the clinical diagnosis. After
uptake into tissues, 99mTc-MIBI is rapidly eliminated.
High uptake of 99mTc-MIBI could be seen just 5 minutes
after intravenous injection and delayed abnormal accu-
mulation imaging could be observed 1 hour later. Similar
results were also reported by Khalkhali et al.2 The abnor-
mal accumulation disappeared 5 hours later.
 Unlike breast cancer, our study showed that early and
delayed imaging did not appear in benign breast lesions.
The T/N ratio of 99mTc-MIBI was lower than 10% in
patients with benign breast lesions.
  The mechanism of 99mTc-MIBI uptake has not been
clearly evaluated. Chiu and colleagues postulated that it
might be related to ionic electroaffinity to fat, intracellular
mitochondria mass, tumour blood supply and cellular
metabolic activity.3 The blood supply of breast cancer is
richer than that of normal breast tissue. The cellular
differentiation and metabolism of breast cancer is abnor-
mally active and this may be an important cause of
99mTc-MIBI uptake in breast cancer.
In our study, false positive imaging was seen in five
chronic mastitis patients and two fibroadenoma patients
with slightly increased 99mTc-MIBI. We inferred that false
positive imaging might be related to cellular mass and
fibrous hyperplasia within these lesions. Waxman et al
also reported similar findings.4 In order to reduce the
chance of false positivity in benign lesions, some authors
used an accumulating index to differentiate benign
lesions from malignant ones.5
The causes of false negative results remain
undetermined. These might be related to smaller,
Figure 1. 99mTc-MIBI breast imaging. Abnormal accumulation
of 99mTc-MIBI (round-shaped density) in the lesion of the right
breast. Anterior position, taken 5 minutes after intravenous
injection of 99mTc-MIBI.
Figure 2. 99mTc-MIBI breast imaging. Slight increase of 99mTc-
MIBI in the lesion of the right breast. Anterior position, taken 1
hour after intravenous injection of 99mTc-MIBI.
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deeper lesions in which abnormal accumulation of
99mTc-MIBI would not be detected by a plain static
imaging device.6 Four false negative 99mTc-MIBI breast
imaging results appeared in lesions smaller than 1 cm
in diameter in our study. Smaller volume of tumour
cells and /or poor blood supply might also be related
to false negativity.7
In cases of slightly increased of uptake within the
breast (Figure 2), malignant lesions should be seriously
considered, and excisional biopsy is recommended.8 In
the present study, two occult lesions with slightly in-
creased of 99mTc-MIBI uptake were pathologically con-
firmed to be breast cancer by ultrasound-guided biopsy.
Slightly increased 99mTc-MIBI uptake also appeared in
three cancerous lesions. It is worthwhile to excise these
lesions in order to rule out malignancy.
In our study, the sensitivity, specificity, positive
predictive value and negative predictive value of 99mTc-
MIBI breast imaging was 89.2%, 88.0%, 75.0% and
95.3%, respectively. These data suggest that 99mTc-MIBI
breast imaging would be very helpful in clinical practice
for the diagnosis of breast cancer. From the results, we
conclude that 99mTc-MIBI breast imaging is of great sig-
nificance in the diagnosis of early breast cancer,
especially for the differentiation between benign and
malignant lesions, as well as for clinically suspicious
lesions.
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